Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heart Failure Patients Registry A Prospective Observational Multicenter Registry of Patients With Chronic Heart Failure in the Population of the Russian Federation (PRIORITY-HF)

NCT04709263 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04709263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04709263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heart Failure Patients Registry A Prospective Observational Multicenter Registry of Patients With Chronic Heart Failure in the Population of the Russian Federation (PRIORITY-HF)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 21, 2020
Completion date
March 28, 2024
Enrollment
19,990 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure